Delivery Order SPE2DB20D2104-SPE2DB23FU27W
- Not listed
- This federal contract award is for the delivery of Orlistat 120 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,976.50, is a delivery order under an Indefinite Delivery Contract (IDC) between the DLA and Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Orlistat 120 mg capsules. The fixed-price delivery order contract, valued at $2,406.80, has an ultimate completion date of September 6, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a large pharmaceutical company, is providing these prescription medications to support various government healthcare...
- This federal contract award is for the delivery of Xenical 120 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed price of $2,776.33 and an ultimate completion date of August 10, 2023. It is a delivery order contract type, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also does...
- The federal contract award is for the delivery of pharmaceutical products, specifically Xenical 120 mg capsules, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order (DO) with a Firm Fixed Price pricing type, valued at $5,898.94, and has an ultimate completion date of October 31, 2023. The contract was awarded on October 30, 2023,...
- The Defense Logistics Agency awarded a $3,980.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120mg Orlistat capsules. As the prime contractor, Amerisourcebergen will provide 90 capsules of the weight management pharmaceutical to fulfill DLA requirements. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility between September 7-8, 2023. No subcontractors or set aside designations were specified. The order is likely placed against...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,765.18, is for the delivery of XENICAL 120 MG CAPSULE 90S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 2, 2023. This appears to be a task order issued under a larger Indefinite Delivery...
- This federal contract award, valued at $2,616.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4559166020 - XENICAL 120 MG CAPSULE 90S, a prescription medication, and has a completion date of November 23, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $3,291.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XENICAL 120 MG CAPSULE 90S, a generic medication, with a performance period that extends through February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,160.75, is for the delivery of XENICAL 120 MG CAPSULE 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of October 14, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award SPE2DB20D2104|SPE2DB23FV32V, with a ceiling value of $2,349.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,163,499 units of the drug XENICAL 120 MG CAPSULE 90S. There is no set-aside designation associated with this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU27WDelivery Order
This federal contract award is for the delivery of ORLISTAT 120 MG CAPSULE 90S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on July 6, 2023 with a ceiling value of $2,519.04. The contract is a Delivery Order under a firm fixed-price arrangement with a completion date of July 7, 2023. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, as well as the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support various government healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/6/23 |